^

Health

Bellastesin

, medical expert
Last reviewed: 23.04.2024
Fact-checked
х

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.

We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.

If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.

Bellastesin is a combined medicine containing in its composition an extract of belladonna, as well as benzocaine.

Indications Bellastesin

The medication is indicated for the removal of spasms in the smooth muscles of the digestive system organs (in particular, for the treatment of spastic stricture), ptimalism (increased salivation), and also for the treatment of hyperacid gastritis.

Release form

Produced in the form of tablets. One blister contains 10 tablets, the package contains 1 blister plate.

Pharmacodynamics

The properties of the drug are due to the effects of its constituent components. Spasmolytic (reducing the tone of the smooth muscles of the organs inside the gastrointestinal tract) and antisecretory action (retardation of the pancreas and stomach, and in addition to salivary, bronchial and sweat secretion, as well as bile secretion) provide alkaloids, included in the atropine category, from the extract of belladonna (this is hyoscyamine, apatropin, as well as scopolamine, etc.). Analgesic effects on the stomach and esophagus mucosa are anesthesin (or benzocaine).

Dosing and administration

Take Bellastesin should be inside at a dosage of 1 tablet three times a day. It must be swallowed completely, without chewing, and then washed with water.

The medicine is applied by a short-term course. If the symptoms do not go away after 3-5 days of treatment, you need to consult a doctor to decide whether to use the drug in the future.

The dosage prescribed in the instructions should not be exceeded.

Use Bellastesin during pregnancy

Pregnant women Bellastesin prescribed only with a high probability of providing therapeutic effects on the mother's body. In this case, this probability should exceed the possible risk of developing negative effects on the fetus.

If you need to use the medicine during the lactation period, you should stop breastfeeding while the treatment is going on.

Contraindications

Among the main contraindications:

  • intolerance to the drug, as well as amide type anesthetics;
  • chronic form of heart failure;
  • atrial fibrillation;
  • presence of hyperthermia syndrome;
  • tachycardia or ischemic heart disease;
  • bleeding in acute form;
  • stenosis of the mitral valve;
  • elevated blood pressure (severe);
  • intestinal obstruction;
  • muscle weakness;
  • hyperthyroidism or glaucoma;
  • retention of urination;
  • childhood.

Side effects Bellastesin

As a result of taking the medicine, it is possible to develop such side effects:

  • deterioration of intestinal motility (may reach the atony), weakening of the tone of the GVP and gallbladder, constipation, development of dysphagia, as well as problems with urination;
  • dry mouth, thirst, disorder of taste buds;
  • development of mydriasis, strengthening of IOP;
  • headaches with dizziness, redness of the face, the appearance of tides, dysarthria, photophobia, weak sweating, and besides paresis;
  • the development of arrhythmia, ischemic heart disease, and a feeling of rhythm of the heartbeat;
  • weakening of excreting activity and bronchial tonus (as a result, viscous, poorly coughing up phlegm forms);
  • a rash on the skin, dryness and itching, and besides hives, anaphylaxis and other anaphylactic reactions, as well as leaf-like dermatitis.

If the patient has symptoms of adverse reactions, immediately stop taking the medication and consult a doctor.

trusted-source

Overdose

Due to an overdose of the drug, the patient may experience an increase in side effects, and in addition develop hyperthermia or tachycardia, vomiting with nausea, a feeling of irritability, agitation or drowsiness. It may also lower blood pressure, tremor, cramps, insomnia and hallucinations. In addition, oppression of the respiratory and vasomotor centers, as well as suppression of the central nervous system, is possible.

The resulting symptoms should be treated with gastric lavage, and then - parenteral administration of cholinomimetics and cholinesterase inhibitors.

Interactions with other drugs

As a result of simultaneous use of Bellastesin and glutetimide, antiarrhythmic anticholinergic drugs, tricyclics, and also amantadine, its anticholinergic effect increases.

Combination of the drug with GCS reduces the effectiveness of the latter, and in addition increases the risk of IOP enhancement.

Simultaneous reception of Bellastezin with atropine-like drugs enhances anticholinergic properties.

As a result of simultaneous use of the drug with furosemide, the risk of developing orthostatic collapse in a patient increases.

For the duration of treatment with Bellastesin it is necessary to refrain from drinking alcohol.

trusted-source[1]

Storage conditions

The drug is contained in standard medical conditions, and also inaccessible to young children. The temperature in the room is not more than + 25 ° С.

trusted-source

Shelf life

Bellastesin is allowed to be used for 3 years from the date of release of the drug.

trusted-source

Attention!

To simplify the perception of information, this instruction for use of the drug "Bellastesin" translated and presented in a special form on the basis of the official instructions for medical use of the drug. Before use read the annotation that came directly to medicines.

Description provided for informational purposes and is not a guide to self-healing. The need for this drug, the purpose of the treatment regimen, methods and dose of the drug is determined solely by the attending physician. Self-medication is dangerous for your health.

Translation Disclaimer: For the convenience of users of the iLive portal this article has been translated into the current language, but has not yet been verified by a native speaker who has the necessary qualifications for this. In this regard, we warn you that the translation of this article may be incorrect, may contain lexical, syntactic and grammatical errors.

You are reporting a typo in the following text:
Simply click the "Send typo report" button to complete the report. You can also include a comment.